Description of Individual Course Units
|
Offered By |
Translational Oncology |
Level of Course Unit |
Third Cycle Programmes (Doctorate Degree) |
Course Coordinator |
PROFESSOR DOCTOR YASEMIN BAŞBINAR |
Offered to |
Translational Oncology |
Course Objective |
Course Objective: fundamental and emerging technologies which is used in preclinical and clinical cancer research will be discussed. |
Learning Outcomes of the Course Unit |
||||||||||||
|
Mode of Delivery |
Face -to- Face |
Prerequisites and Co-requisites |
None |
Recomended Optional Programme Components |
None |
Course Contents |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Recomended or Required Reading |
Turner, J. Rick. New Drug Development. An Introduction to Clinical Trials: Second Edition. 2010. Springer
|
Planned Learning Activities and Teaching Methods |
Lectures, the topics with classroom activities (presentations and homework assignments) to consolidate and discussion |
Assessment Methods |
||||||||||||||||||||||||||||
*** Resit Exam is Not Administered in Institutions Where Resit is not Applicable. |
Further Notes About Assessment Methods |
None |
Assessment Criteria |
1. The learner will clearly define outlined LO1, LO3, LO5, and which will evaluate with exam. |
Language of Instruction |
Turkish |
Course Policies and Rules |
To be announced. |
Contact Details for the Lecturer(s) |
ilhan.oztop@deu.edu.tr ; 0 232 412 58 01 |
Office Hours |
Thursday 11:00-12:00 |
Work Placement(s) |
None |
Workload Calculation |
||||||||||||||||||||||||||||||||||||||||
|
Contribution of Learning Outcomes to Programme Outcomes |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|